Css LLC Exact Sciences Corp Call Options Transaction History

Css LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $328,713 - $468,996	-3,300 Reduced 29.2%	8,000 $1.06 Million
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $557,500 - $927,500	-10,000 Reduced 46.95%	11,300 $982,000
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $132,650 - $365,540	-3,500 Reduced 14.11%	21,300 $1.24 Million
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $1.77 Million - $2.27 Million	22,800 Added 1140.0%	24,800 $2.29 Million
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $361,480 - $489,960	-4,000 Reduced 66.67%	2,000 $181,000
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $179,020 - $236,080	2,000 Added 50.0%	6,000 $708,000
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $61,980 - $96,500	1,000 Added 33.33%	4,000 $347,000
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $144,870 - $241,799	-3,000 Reduced 50.0%	3,000 $237,000
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $238,920 - $345,180	6,000 New	6,000 $242,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.